Ca2+ ATPase activity in essential and renal hypertension

Clin Exp Hypertens. 1993 Jan;15(1):143-52. doi: 10.3109/10641969309041616.

Abstract

In 15 patients with essential hypertension, 16 patients with renal hypertension and in 12 healthy subjects Ca2+ ATPase activity was determined in red blood cells both in the basal state and after maximal stimulation with calmodulin. Normal subjects showed a basal and maximal activity of 7.1 +/- 3.6 and 16.0 +/- 2.3 pmol phosphate/min.10(6) RBC, respectively. Renal hypertensives had a similar basal Ca2+ ATPase activity (5.4 +/- 4.1 pmol phosphate/min.10(6) RBC) and a lowered maximal Ca2+ ATPase activity (9.8 +/- 5.4 pmol phosphate/min.10(6) RBC, p < 0.05). In essential hypertensives basal and maximal Ca2+ ATPase activity was 9.0 +/- 5.3 and 35.4 +/- 14.4 pmol phosphate/min.10(6) RBC, respectively, the latter being significantly increased (p < 0.01). This finding, which is in contrast to earlier results indicating a lowered Ca2+ ATPase activity in essential hypertension, may be explained as a consequence of an increased Ca2+ influx in essential hypertension. A lowered Ca2+ ATPase activity does not seem to be involved in the pathogenesis of essential hypertension.

MeSH terms

  • Adult
  • Calcium / blood
  • Calcium-Transporting ATPases / blood*
  • Calmodulin / pharmacology
  • Erythrocytes / drug effects
  • Erythrocytes / enzymology
  • Female
  • Humans
  • Hypertension / blood
  • Hypertension / enzymology*
  • Hypertension / etiology
  • Hypertension, Renal / blood
  • Hypertension, Renal / enzymology*
  • Hypertension, Renal / etiology
  • In Vitro Techniques
  • Male
  • Middle Aged

Substances

  • Calmodulin
  • Calcium-Transporting ATPases
  • Calcium